Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance.

A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance. Abstract Text:

    iryna zubovychIryna Zubovych,thomas doundoulakisThomas Doundoulakis,patrick g harranPatrick G Harran,michael g rothMichael G Roth,

    Hemiasterlin is a potent antimitotic peptide that interferes with microtubule dynamics at picomolar concentrations in cell culture. The molecule largely eludes P glycoprotein-mediated drug efflux, and an analog is currently being evaluated in clinical trials as cancer chemotherapy. From a nonclonal genetic screen in Caenorhabditis elegans we isolated eight independent mutants resistant to a synthetic hemiasterlin analog. In one recessive mutant, phb-2(ad2154), a point mutation in prohibitin 2 (E130K) protects worms from drug-induced injury. Data indicate that direct binding of hemiasterlin to prohibitin 2 is unlikely. In fact, C. elegans phb-2(ad2154) was also found to be resistant to numerous other drugs that bind tubulin and to camptothecin, yet this mutant was sensitive to nocodazole and phalloidin. Thus, prohibitin 2 is implicated in a previously uncharacterized pathway of multidrug resistance.

    A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance. Publishing Authors By Initials

    i zubovychI Zubovych,t doundoulakisT Doundoulakis,pg harranPG Harran,mg rothMG Roth,

    For similar chemical actions and uses: pharmacologic actions: molecular mechanisms of pharmacological action: mitosis modulators: antimitotic agents: tubulin modulators research abstracts see: chemical actions and uses: pharmacologic actions: molecular mechanisms of pharmacological action: mitosis modulators: antimitotic agents: tubulin modulators research

    PUBMED ID PMID:

    MEDLINE DATE:

    A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Proceedings of the National Academy of Sciences of

    VOLUME: 103

    Page Numbers: 15523-8

    Journal Abbreviation: Proc. Natl. Acad. Sci. U.S.A.

    ISSN: 0027-8424

    DAY: 10

    MONTH: 10

    YEAR: 2006

    A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7505876

    A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance. Keywords Mesh Terms:

    KEYWORDS: Tubulin Modulators

    MESH TERMS: pharmacology

    Chemical & Substance for Abstract: A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance. Information

    Substance Name: Nocodazole

    Registry Number: 31430-18-9

    Grant and Affiliation Information for A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance.

    AFFILIATION: Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9038, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: P01CA95471

    ACRONYM: CA

    MEDLINETA: Proc Natl Acad Sci U S A

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News